pDEST51-LRRK2-G2019S Citations (4)

Originally described in: Cookson Lab Plasmids
Unpublished

---

Articles Citing pDEST51-LRRK2-G2019S

Articles
A proteomic analysis of LRRK2 binding partners reveals interactions with multiple signaling components of the WNT/PCP pathway. Salasova A, Yokota C, Potesil D, Zdrahal Z, Bryja V, Arenas E. Mol Neurodegener. 2017 Jul 11;12(1):54. doi: 10.1186/s13024-017-0193-9. PubMed
Patient-Specific iPSC-Derived Astrocytes Contribute to Non-Cell-Autonomous Neurodegeneration in Parkinson's Disease. di Domenico A, Carola G, Calatayud C, Pons-Espinal M, Munoz JP, Richaud-Patin Y, Fernandez-Carasa I, Gut M, Faella A, Parameswaran J, Soriano J, Ferrer I, Tolosa E, Zorzano A, Cuervo AM, Raya A, Consiglio A. Stem Cell Reports. 2019 Feb 12;12(2):213-229. doi: 10.1016/j.stemcr.2018.12.011. Epub 2019 Jan 10. PubMed
NME1 Protects Against Neurotoxin-, alpha-Synuclein- and LRRK2-Induced Neurite Degeneration in Cell Models of Parkinson's Disease. Anantha J, Goulding SR, Tuboly E, O'Mahony AG, Moloney GM, Lomansey G, McCarthy CM, Collins LM, Sullivan AM, O'Keeffe GW. Mol Neurobiol. 2022 Jan;59(1):61-76. doi: 10.1007/s12035-021-02569-6. Epub 2021 Oct 8. PubMed
Blocking IL-6 signaling prevents astrocyte-induced neurodegeneration in an iPSC-based model of Parkinson's disease. Pons-Espinal M, Blasco-Agell L, Fernandez-Carasa I, Andres-Benito P, di Domenico A, Richaud-Patin Y, Baruffi V, Marruecos L, Espinosa L, Garrido A, Tolosa E, Edel MJ, Otero MJ, Mosquera JL, Ferrer I, Raya A, Consiglio A. JCI Insight. 2024 Feb 8;9(3):e163359. doi: 10.1172/jci.insight.163359. PubMed

If you have published an article using this material, please email us at to have your article added to this page.